Cerulean Pharma reported $-8400450 in EBIT for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Adamis Pharmaceuticals ADMP:US -7913290 3.19K
Agile Therapeutics AGRX:US $ -15573000 6.78M
Arrowhead Research ARWR:US $ 41.55M 104.87M
Bayer BAYN:GR 4.17B 704M
Biocept BIOC:US $ -2707000 68.54K
Brainstorm Cell Therapeutics BCLI:US $ -5475000 737K
Cerulean Pharma CERU:US $ -8400450 1.14M
Immunogen IMGN:US $ -22852000 11.7M
Johnson & Johnson JNJ:US $ 7540M 1623M
Macrogenics MGNX:US $ -66638000 8.4M
Merk MRK:US $ 5059M 207M
Nektar Therapeutics NKTR:US $ -115085000 2.17M
Perrigo Ordinary Shares PRGO:US $ 23.1M 39.7M
Pfizer PFE:US $ 9995M 4136M
Seattle Genetics SGEN:US $ -133050000 39.02M
YTE INCY:US $ 127.66M 7.71M